EA201170843A1 - Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью - Google Patents

Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью

Info

Publication number
EA201170843A1
EA201170843A1 EA201170843A EA201170843A EA201170843A1 EA 201170843 A1 EA201170843 A1 EA 201170843A1 EA 201170843 A EA201170843 A EA 201170843A EA 201170843 A EA201170843 A EA 201170843A EA 201170843 A1 EA201170843 A1 EA 201170843A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
biodusability
preliminaryly
low oral
medicinal forms
Prior art date
Application number
EA201170843A
Other languages
English (en)
Other versions
EA019147B1 (ru
Inventor
Ян П. Мешвитцер
Юй-Сань У
Софи Р. Ван Томме
Хенни Кейл
Алдо В. Кет
Люсия Мария Дусбюрг-Девит
Original Assignee
Эбботт Хелткэа Продактс Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эбботт Хелткэа Продактс Б.В. filed Critical Эбботт Хелткэа Продактс Б.В.
Publication of EA201170843A1 publication Critical patent/EA201170843A1/ru
Publication of EA019147B1 publication Critical patent/EA019147B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретение относится к области фармацевтической химии. Варианты осуществления настоящего изобретения относятся к предварительно спрессованным быстро распадающимся лекарственным формам соединений с низкой пероральной биодоступностью.
EA201170843A 2008-12-19 2009-12-17 Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью EA019147B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13919308P 2008-12-19 2008-12-19
EP08172247 2008-12-19
PCT/EP2009/067434 WO2010070057A2 (en) 2008-12-19 2009-12-17 Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability

Publications (2)

Publication Number Publication Date
EA201170843A1 true EA201170843A1 (ru) 2012-02-28
EA019147B1 EA019147B1 (ru) 2014-01-30

Family

ID=40536155

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170843A EA019147B1 (ru) 2008-12-19 2009-12-17 Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью

Country Status (21)

Country Link
US (1) US20110257158A1 (ru)
EP (1) EP2379061B1 (ru)
JP (1) JP5669751B2 (ru)
KR (1) KR20110104059A (ru)
CN (1) CN102395360A (ru)
AR (1) AR074689A1 (ru)
AU (1) AU2009327068A1 (ru)
BR (1) BRPI0922406A2 (ru)
CA (1) CA2747345C (ru)
CO (1) CO6390098A2 (ru)
DO (1) DOP2011000194A (ru)
EA (1) EA019147B1 (ru)
EC (1) ECSP11011138A (ru)
ES (1) ES2393530T3 (ru)
IL (1) IL213604A0 (ru)
MX (1) MX2011006691A (ru)
PE (1) PE20110923A1 (ru)
SG (1) SG172246A1 (ru)
TW (1) TW201028168A (ru)
WO (1) WO2010070057A2 (ru)
ZA (1) ZA201104907B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109803931A (zh) 2016-10-05 2019-05-24 博爱新开源医疗科技集团股份有限公司 含有交联聚乙烯吡咯烷酮的片剂组合物及其在饮料应用中的用途
KR20200024890A (ko) * 2017-07-05 2020-03-09 노파르티스 아게 신규한 약학적 조성물
KR102227745B1 (ko) * 2017-12-18 2021-03-15 성균관대학교산학협력단 분해도 제어가 가능한 크라이오젤 스캐폴드 및 상기 스캐폴드에 고형암 미세환경에서 면역억제작용을 제어하는 약물을 로딩한 연성 생체삽입소자

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
ES2306492T3 (es) * 1999-07-19 2008-11-01 Fit Gmbh Producto polisacarido coelaborado con polivinilpirrolidona reticulada.
GB0204771D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
JP4523265B2 (ja) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 排尿障害治療用口腔内崩壊製剤
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone
US20070020334A1 (en) * 2005-07-11 2007-01-25 Poul Bertelsen Benzimidazole formulation
US7923026B2 (en) * 2006-10-20 2011-04-12 Solvay Pharmaceuticals B.V. Embedded micellar nanoparticles
WO2008148731A1 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
CN101707930B (zh) * 2007-06-06 2013-10-30 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
DE102007027067A1 (de) * 2007-06-12 2008-12-18 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Vardenafil Hydrochlorid Trihydrat

Also Published As

Publication number Publication date
WO2010070057A2 (en) 2010-06-24
AR074689A1 (es) 2011-02-02
KR20110104059A (ko) 2011-09-21
CA2747345C (en) 2017-05-16
WO2010070057A3 (en) 2010-08-19
ZA201104907B (en) 2012-03-28
SG172246A1 (en) 2011-07-28
AU2009327068A1 (en) 2011-07-14
PE20110923A1 (es) 2012-01-09
JP2012512836A (ja) 2012-06-07
EA019147B1 (ru) 2014-01-30
ECSP11011138A (es) 2011-07-29
DOP2011000194A (es) 2011-07-31
CA2747345A1 (en) 2010-06-24
JP5669751B2 (ja) 2015-02-18
IL213604A0 (en) 2011-07-31
ES2393530T3 (es) 2012-12-26
US20110257158A1 (en) 2011-10-20
BRPI0922406A2 (pt) 2015-12-15
CO6390098A2 (es) 2012-02-29
EP2379061A2 (en) 2011-10-26
CN102395360A (zh) 2012-03-28
MX2011006691A (es) 2011-07-28
EP2379061B1 (en) 2012-11-14
TW201028168A (en) 2010-08-01

Similar Documents

Publication Publication Date Title
EA201200937A1 (ru) Твердая лекарственная форма тикагрелора
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201300146A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ
EA201300388A1 (ru) Соединения замещенного бензамида
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
EA201170441A1 (ru) Терапевтические противовирусные пептиды
MY187718A (en) Pharmaceutical formulations
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
EA201190125A1 (ru) Таблетки для комбинированной терапии
MX340188B (es) Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
EA201170512A1 (ru) Композиция для перорального введения
CR20110704A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
EA201171414A1 (ru) Ингибиторы белков семейства iap
EA201001353A1 (ru) Гидробромид ивабрадина
TR200900882A2 (tr) Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
EA200970816A1 (ru) Новая лекарственная форма
EA201170843A1 (ru) Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
UA105285C2 (ru) Твердая фармацевтическая лекарственная форма рамиприла и безилата амлодипина и ее получение
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
MX2012008253A (es) Uso farmaceutico de compuestos multiciclicos como agentes anti-sindrome de inmunodeficiencia adquirida.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM